Technopharm Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-12-2024
- Paid Up Capital ₹ 0.50 M
as on 17-12-2024
- Company Age 50 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.65 M
as on 17-12-2024
- Revenue 10.85%
(FY 2022)
- Profit -30.54%
(FY 2022)
- Ebitda -11.04%
(FY 2022)
- Net Worth 8.51%
(FY 2022)
- Total Assets 16.26%
(FY 2022)
About Technopharm
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.65 M.
Jogendra Singh, Divya Bhatia, Anju Bhatia, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24231UP1974PTC003859
- Company No.
003859
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 1974
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Technopharm Private Limited offer?
Technopharm Private Limited offers a wide range of products and services, including Pharmaceutical Medicine, Herbs,Sticks and Roots, Psyllium Husk, Liver Supplement, Liver Capsule, Pharmaceutical Tablets, Pain Relief Drugs & Pharmaceuticals, Pain Killers, Herbal Oil, Massage Oil.
Who are the key members and board of directors at Technopharm?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jogendra Singh  | Director | 07-Jun-2019 | Current |
| Divya Bhatia | Director | 19-Apr-1997 | Current |
| Anju Bhatia | Whole-Time Director | 19-Apr-1997 | Current |
| Dheeraj Bhatia | Whole-Time Director | 23-Sep-1997 | Current |
| Bina Bhatia | Whole-Time Director | 19-Apr-1997 | Current |
| Arun Bhatia | Additional Director | 25-Mar-2024 | Current |
Financial Performance of Technopharm.
Technopharm Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.85% increase. The company also saw a substantial fall in profitability, with a 30.54% decrease in profit. The company's net worth moved up by a moderate rise of 8.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Technopharm?
In 2022, Technopharm had a public holding of 35.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 11 Jan 1984 | ₹0.10 M | Open |
Bank Of Baroda Creation Date: 28 Sep 1983 | ₹0.25 M | Open |
Bank Of Baroda Creation Date: 14 Feb 1983 | ₹0.30 M | Open |
How Many Employees Work at Technopharm?
Technopharm has a workforce of 80 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Technopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Technopharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
